Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification

George J. Netto, Mahul B. Amin, Éva Compérat, Anthony J. Gill, Arndt Hartmann, Holger Moch, Santosh Menon, Maria Rosaria Raspollini, Mark A. Rubin, John R. Srigley, Puay Hoon Tan, Satish K. Tickoo, Toyonori Tsuzuki, Samra Turajlic, Ian A. Cree, Daniel M. Berney